News Category |
News DetailsSanofi Net Jumps 61%Sanofi-Aventis reported a 61% rise in net profit and will conduct "another re-evaluation" of the structure of its U.S. sales force in light of looming generic competition to the company's blockbuster drug Lovenox. |
Sponsors |